guide peptide FAQ

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 1250 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 1250 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Lipo-C is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Discard it immediately. Cloudiness or visible particles indicate protein aggregation or bacterial contamination—both render the solution unsafe and ineffective. Properly reconstituted IGF-1 LR3 should be clear and colourless. Aggregation occurs when the peptide is exposed to temperatures above 25°C for extended periods or when reconstituted with non-sterile water. Injecting aggregated protein can trigger immune responses that reduce future receptor sensitivity. Our team recommends reconstituting only the volume you'll use within 2 weeks to minimise degradation risk.

Resume at the next scheduled dose—do not double-dose. Missing a single injection reduces cumulative anabolic signaling but doesn't reset the recovery process. IGF-1 LR3's extended half-life provides some carry-over effect, so a missed Monday injection still leaves residual plasma levels on Tuesday. Missing 3+ consecutive doses per week, however, drops plasma levels below the threshold needed for sustained satellite cell activation, which diminishes the protocol's effectiveness. Consistency across the 4–6 week cycle matters more than perfection on any single day.

Yes, and it's recommended. IGF-1 LR3's 20–30 hour half-life means plasma levels from a Monday injection remain elevated through Tuesday evening. Injecting on rest days maintains steady-state receptor saturation, which prevents the drop-off in satellite cell signaling that occurs when dosing only on training days. Research protocols that dose 5–6 days per week (including rest days) show superior cumulative hypertrophy compared to training-day-only protocols—the satellite cell proliferation window extends beyond the training stimulus itself.

IGF-1 LR3 stacks synergistically with peptides that target complementary pathways. BPC-157 enhances connective tissue repair and modulates inflammatory cytokines, addressing tendon and ligament recovery that IGF-1 LR3 doesn't directly target. Thymalin supports immune function and thymic peptide signaling, which can be suppressed during high-volume training blocks. Avoid combining IGF-1 LR3 with insulin or GH secretagogues without medical oversight—stacking compounds that all lower blood glucose or stimulate IGF-1 signaling creates hypoglycemia risk and receptor desensitisation.